Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program

SIMPLE SUMMARY: Patients receiving oral anticancer agents (OAAs) have a substantial symptom burden. Given the trend toward patient-centered care, the use of patient-reported outcomes (PROs) seems appropriate to secure medication management, and to improve clinical decision-making. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Collomb, Bastien, Dubromel, Amélie, Caffin, Anne Gaëlle, Herledan, Chloé, Larbre, Virginie, Baudouin, Amandine, Cerutti, Ariane, Couturier, Laurence, Maire, Magali, Karlin, Lionel, Maucort-Boulch, Delphine, Huot, Laure, Dalle, Stéphane, Bachy, Emmanuel, Ghesquieres, Hervé, Salles, Gilles, Couraud, Sébastien, You, Benoit, Freyer, Gilles, Trillet-Lenoir, Véronique, Ranchon, Florence, Rioufol, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833408/
https://www.ncbi.nlm.nih.gov/pubmed/35158928
http://dx.doi.org/10.3390/cancers14030660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833408/
https://www.ncbi.nlm.nih.gov/pubmed/35158928
http://dx.doi.org/10.3390/cancers14030660

Ejemplares similares